Myriad Genetics (MYGN)
(Delayed Data from NSDQ)
$7.50 USD
+0.19 (2.60%)
Updated Sep 16, 2025 04:00 PM ET
After-Market: $7.50 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth D Momentum B VGM
Fundamental Charts
About Dividend Yield (TTM)
Myriad Genetics, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
MYGN 7.50 +0.19(2.60%)
Will MYGN be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for MYGN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MYGN
Is it a Prudent Move to Retain MYGN Stock in Your Portfolio Now?
MYGN Stock Might Gain on The Lancet Study Backing Precise MRD
MYGN: What are Zacks experts saying now?
Zacks Private Portfolio Services
MYGN's GeneSight Test Proven Superior to TAU: Stock to Gain?
Compared to Estimates, Myriad (MYGN) Q2 Earnings: A Look at Key Metrics
Myriad Genetics (MYGN) Q2 Earnings and Revenues Surpass Estimates
Other News for MYGN
Technical picture remains unchanged for MYGN after it rises 0.97% on September 15
MYGN forms Upper Bollinger Band Walk on September 12
Is MYGN primed for upward momentum? Expansion Breakout shows up after rallying 11.3%
MYGN Crosses Above Average Analyst Target
The technical outlook for MYGN is unchanged after it falls 1.0% on September 10